| Pharma Finance 2009 |
|---|
| Aziende Italiane |
|
|
|
Company Profiles Profilo delle aziende che hanno preso parte alla III edizione del Pharma Finance.
Per visionare i profili completi delle aziende scarica il Catalogo del Congresso.
|
|
Cancer Research |
| Dept. of Drug Research and Evaluation |
|
Dept. of Veterinary Public Health and Food Safety - Food and Veterinary Toxicology Unit (DVPHFS) |
|
Device for small animal imaging and molecular imaging |
|
FaBioCell |
| Translational Research |
LifeLineLab
Lifelinelab Srl started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. Nowadays the company mission is to face and develop markets with consolidate and emerging technologies such as Microarrays using a proprietary chemistry patented and designed to covalently bind either Protein or Nucleic acids which allows the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.
Mavi Sud Srl
Mavi Sud produces cosmeceuticals and nutraceuticals formulated from its own R&D laboratories. All the products are distributed in Pharmacies and Beauty Centres by medical prescription. . All the lines are charaterized from innovative active ingredients and vehicles based on chitin nanofibrilis (CN) patented worldwide.
MBS Srl
MBS srl (Micro Biological Survey): (Limited Liability Co.) is a recent spin-off of Roma Tre University, participated by the Roma Tre University itself, the researchers who set-up the method, an Italian small biotech firm and INVENT, a France seed-capital company. The business idea is to produce and to commercialize an analytical kit patented by University Roma Tre which utilizes disposable, ready-to-use reaction vials for fast microbiological analyses of food and water samples.
Medi Pragma Srl
Medi Pragma is the first Italian Market Research specialized in healthcare marketing is located in Rome and Milan. Since 1984, we offer tailor-made solutions to Pharmaceutical, cosmetic and diagnostic Companies. They propose the project "Euro Oncology Italy II": a database analysing 1800 clinical cases, involving 180 specialists in 120 different Italian Hospitals. Euro Oncology is a complete database suitable for knowing, analysing and assessing the Cancer market.
Menarini Biotech Srl
Menarini Biotech since 1986 represents a Centre of Excellence in Italy for Biotechnology. They provide customised development and manufacturing services for protein production in compliance with to the highest regulatory standards (both European and FDA cGMP) and we are licensed by the Italian Ministry of Health for the manufacture of clinical supply for human use. They are experienced in producing recombinant proteins, DNA, mAbs and biosimilars from mammalian, hybridomas and micro-organisms.
Microbo Srl
Microbo srl has developed and patented some products to prevent and cure hypoferremia and iron deficiency anaemia in pregnant women and in subjects suffering of iron deficiency and iron deficiency anaemia; to prevent and cure microbial and viral infections; to prevent and cure mucosal inflammations; to prevent and cure mucosal infections; to prevent and cure gingivitis and periodontitis.
Miros
Miros medical technology LTD is a young company with headquarters in Italy and Bulgaria. The company is involved in research, the creation, design and development of new and original medical devices for treating fractures percutaneous as the application of plaques following the gradual replacement of traditional techniques that use with other surgical approaches reduced or type percutaneous and, therefore, little bloody and less sacrifice bone.
Mo.Li.Rom Srl
MoLiRom Srl is a spin-off company of the “Sapienza” University of Rome. The mission of MoLiRom is focussed on the research and development of advanced projects in the synthesis and production of bioactive substances spanning from pharmaceutical intermediates and natural products to biotech pharmaceuticals.
MuroTherapy
MuroTherapy is an academic spin-off. They developed a certain number of muramylpeptides blends, derived by genetically modified bacteria, useful as immunostimulatory molecules under physiological conditions and in pathological disorders.
NeuroEngage
NeuroEngage is a spin-off company from the University of Rome "La Sapienza".The company has developed innovative biomarkers that allow to understand if the commercial spots (on the TV or Internet) would be memorized and/or had emotionally engaged the final users.
Orofino Pharmaceuticals Group
The Orofino Pharmaceuticals Group is made by third party companies that work in the pharmaceutical and cosmetic markets:
Biopharma : In totally segregated buildings, the third party manufacturing of the most forms of beta-lactams antibiotics takes place: Penicillins, Cephalosporins and Penems.
Injectalia : In independent buildings Injectalia manufactures, PreFilled Preventis™ syringes for biotech and other products, Hemoderivatives ,Aseptic filling of solutions and diluents in ampoules, Phase I, II & III clinical trials' products.
K24 Pharmaceuticals : The plant offers chemical testing, all-kind pharmaceutical secondary packaging, controlled-temperature Warehouse for pharmaceuticals products.
Achir Pharma : The Orofino Group by grounding Achir Pharma went in the Cosmetic Market.
Quattroemme Spa
Quattroemme Spa has consolidated its experience in Groupware, Collaboration and Corporate Portal themes. The company has developed BKM Suite for Business Knowledge Management focused on creating the “virtual organization” where is possible to collaborate in a simple and efficient way. The company has built a considerable experience in both analytical and methodology areas (Business Intelligence themes).
RSO Spa
RSO develops knowledge, enhances value and produces solutions. RSO is a dynamic, knowledge company that carries out organizational and managerial innovation projects in partnership with clients.
San Raffaele Biomedical Park Foundation
The non profit foundation San Raffaele Biomedical Park Foundation (SPR) strives to establish communication between science and technology of uncompromised quality, and the development of innovation with applicative, medical and economical significance.
SpaceLand Srl
SpaceLand has become de facto the first non-gov. aerospace agency providing end-to-end services to prepare people from 11 to 93 years of age and experimental hardware for Zero-gravity flights for Research Flight Campaigns open to the general public. They propose development and testing of new therapies and drugs on board the spaceland flying lab benefiting from accelerated dynamics in weightlessness of stem cells and osteoporosis phenomena.
TDA - Technology Development for Africa Srl
Technology Development for Africa Srl started as spin-off company of University of Rome “Tor Vergata”, is settled in the Scientific Park of the University. TDA provides strategic consultancy to start-up projects in research, development and diagnostic programmes in biomedical field.
Unibiomedics Srl
Unibiomedics is a spin off company between university and industry, constituted in November 2008. The core business is to design, fabricate and test biomedical prototypes internationally patented. They propose the development of novel intraoperative probes for the survey of β and γ rays emitted from radionuclides, surgical scintigraphic FDG probe for cancer identification.
University of Rome Campus Biomedico
The University Campus Bio-Medico of Rome has an internationally recognized expertise in translational models of drug-induced cardiotoxicity. This is of interest to Bio-Tech and Pharmaceutical Companies at the stage of drug development, preclinical testing, and implementation of Phase I and II studies. Moreover, this site is working at finalizing and operating a Clinical Trial Unity that meets regulatory requirements for Phase I - II, bioequivalence, biosimilarity studies.
University of Rome "La Sapienza" - Dept. of Experimental Medicine and Pathology
The project proposal comes from the Department of Experimental Medicine and Pathology, Faculty of Medicine, University of Rome "La Sapienza". Their invention is related to a method of in vitro analysis to identify patients that have a reduced aspirin action due to the mechanisms that we discovered, including genetic polymorphisms correlate either with expression or functionality of the transporter.
University of Rome "Tor Vergata" - Department of Biology
The main topic of the Laboratory of Immunology and Molecular Pathology, at the Department of Biology, University of Rome “Tor Vergata”, is to study at cellular and molecular level the host-pathogen interaction in the course of HIV or Mycobacterium tuberculosis infection. In particular, research activity of the laboratory is focused on the definition of pathogenetic mechanisms and on identification of new correlates of protection during these diseases.
University of Rome "Tor Vergata"
Faculty of Mathematics, Physics and Natural Science
The Faculty of Mathematics, Physics and Natural Science of the University of Rome "Tor Vergata" is considered among the most important scientific disciplines at the national level. One of its strengths is the avant-garde scientific research, in collaboration with major national and international research centres.
Ylichron Srl
Founded in 2005, Ylichron is the first spin off company of ENEA. Ylichron mission is to design and realise systems for High Perfomance Computing (HPC) in many areas such as bioinformatics, molecular modelling, Artificial Intelligence. Ylichron has developed a proprietary tool, HCE (HARWEST Compiler Environment) for the automatic design of HPC architectures. The company has relevant competences also in the field of software engineering.
WetWare Concepts Srl
Wetware Concepts Srl is a Spin Off of the University of Padua with an operative unit located in Rome. The company is an R&D with a interdisciplinary and strong team (biologist, nanotechnologist, microelectronic engineers, molecular biologist) focused in wetware biosensors. The two main projects under development are: a new whole-living-cell biosensors aimed to detect doping and drug elements; a new nano-structured sensors based on commercial technologies.